Molecular epidemiology of Hepatitis B virus in Córdoba, Argentina
Section snippets
Background
It is estimated that more than 2 billion people have been infected with hepatitis B virus (HBV) [1], and 350 million individuals have been diagnosed with chronic HBV infection worldwide [2], [3].
Based on a genetic diversity of 8% in the entire genomic sequence, the HBV has been classified at least into nine genotypes (A-I) which have a worldwide geographical distribution [4], [5]. These distribution of HBV genotypes (gt) and subtypes (sgt) are markedly heterogeneous throughout the world, even
Objectives
The aim of this study was to molecularly characterize HBV isolates from central Argentina (Córdoba province), in order to determine the gt, sgt and the presence of mutations of potential clinical relevance.
Samples
This was a retrospective study (from January 2009 to December 2011) of 52 adult, unrelated individuals with HBV infection, determined by the presence of surface antigen (HBsAg), inhabitants of Córdoba City, and other small cities and towns from Córdoba province.
Phylogenetic analysis
Based on the phylogenetic analysis, the 40 sequences obtained from mono-infected patients grouped as following: 14 belonged to sgt F1b (35%), 7 to sgt F4 (17.5%), 15 to sgt A2 (37.5%), 2 to gt C (5%), and 2 to gt D (5%). Samples assigned to gt C could not be subgenotyped (n = 2); for gt D, one sample grouped within sgt D2, and the other could not be defined. Among HIV/HBV co-infected patients, sgt A2 was the most prevalent (75%), followed by sgt F1b (25%) (Fig. 1).
Statistical analyses showed
Discussion
The present study reveals the gt distribution of HBV in Córdoba, Argentina, showing the presence of two distinct epidemiological scenarios, according to the study group: HBV mono-infected and HBV–HIV co-infected patients. The 40 samples from mono-infected individuals grouped as: gts F (52.5%), A (37.5%), C (5.0%) and D (5.0%). The gt F distribution at Córdoba province present an intermediate value between those observed for Buenos Aires (around 30%) [17] and for Northwest Provinces (around 90%)
Funding
This study was supported by grants of Secyt-National University of Córdoba (Secyt: 05/H343) and Alberto J. Roemmers Fundation (2012–2013).
Conflict of interests
None declared.
Ethical approval
This work is part of a research project inscribed and approved by the ethics committee of the Health Ministry of the Province of Cordoba (RepisNro002).
Authors’ contributions
VR and RC were involved in the study design, the analysis of the data and in the process of writing the manuscript. FG, LC and MMW carried out the experiments. FG, MBP, CT and MB were involved in the analysis of data and in the process of writing the manuscript. CT and RC performed statistical and phylogenetic analyses.
Acknowledgements
We would like to thank Osvaldo Elbarcha, who facilitated us the samples, and Javier Aguilar, who helped us in the preparation of the figure.
MBP and CT are recipients of CONICET post-doctoral fellowships of Argentina. VR and RC are members of the researcher career of CONICET, Argentina.
References (47)
- et al.
Viral hepatitis B
Lancet
(2003) - et al.
Phylogenetic analysis and subgenotypic distribution of the hepatitis B virus in Recife, Brazil
Infect Genet Evol
(2013) - et al.
Identification of four novel subgenotypes (C13–C16) and two inter-genotypic recombinants (C12/G and C13/B3) of hepatitis B virus in Papua province, Indonesia
Virus Res
(2012) - et al.
Hepatitis B virus in Buenos Aires, Argentina: genotypes, virological characteristics and clinical outcomes
Clin Microbiol Infect
(2011) - et al.
Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV–HIV coinfected patients: a 3-yr prospective study
J Clin Virol
(2009) - et al.
New natural variants of hepatitis B virus among Amerindians from Argentina with mainly occult infections
J Clin Virol
(2012) - et al.
Molecular epidemiology and genetic diversity of hepatitis B virus in Mar del Plata city, Argentina
Infect Genet Evol
(2013) EASL clinical practice guidelines: management of chronic hepatitis B virus infection
J Hepatol
(2012)Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact
J Clin Virol
(2005)- et al.
HBV mutations and their clinical significance
Adv Med Sci
(2012)
Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production
Gastroenterology
Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus
Int J Infect Dis
Influence of overlapping genes on the evolution of human hepatitis B virus
Virology
The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa
Vaccine
Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
Lancet
Hepatitis B e antigen-negative chronic hepatitis B
Hepatology
Global epidemiology of hepatitis B virus
J Clin Gastroenterol
Bayesian estimates of the evolutionary rate and age of hepatitis B virus
J Mol Evol
Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes
Intervirology
Molecular epidemiology of hepatitis B virus Korean
J Intern Med
Clinical relevance and public health significance of hepatitis B virus genomic variations
World J Gastroenterol
Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9
Arch Virol
Analysis of the full-length genomes of novel hepatitis B virus subgenotypes C11 and C12 in Papua, Indonesia
J Med Virol
Cited by (12)
Hepatitis B virus American genotypes: Pathogenic variants ?
2020, Clinics and Research in Hepatology and GastroenterologyCitation Excerpt :In countries with a lower frequency of Amerindian genes, but where the contribution of African genes is even lower, such as Argentina, Chile, Colombia and Venezuela, HBV genotype F is also predominant. In Argentina, marked differences are observed in the prevalence of genotype F between the capital and other regions, being a reflection of the degree of admixture between European and Amerindian genes in each group [23–26]. In contrast, in Brazil, where the Amerindian contribution to the mtDNA genetic pool is lower than the African one, HBV genotype F is not predominant, even in indigenous populations.
New pieces on genetic diversity and evolutionary history of hepatitis B virus: Characterization of the novel subgenotype F6
2017, Infection, Genetics and EvolutionMolecular epidemiology of hepatitis B virus in Misiones, Argentina
2016, Infection, Genetics and EvolutionCitation Excerpt :The time-scaled MCCT showed that the three sequences would have a common ancestor dated only four years before the sampling date, suggesting that, unlike the gt-D, the F1b has been recently introduced in Misiones. This is consistent with the current epidemiological data from other regions of Argentina, pointing to this sgt as responsible for most of the acute and new chronic HBV infections (Barbini et al., 2013; Gallego et al., 2014; González López Ledesma et al., 2015; Pezzano et al., 2011). The sgt-F4 isolates from Misiones exhibited a higher genetic distance and an older ancestor than F1b, and a disperse distribution in the MCCT, with the exception of one cluster having two sequences.
Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling
2020, Journal of Cellular and Molecular Medicine